Chemoinformaics analysis of 6,6-Dimethyl-2-methylenebicyclo[3.1.1]hept-3-yl acetate
| Molecular Weight | 194.274 | nRot | 1 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 14 |
| Exact Molecular Weight | 194.131 | nRing | 3 |
| Solubility: LogS | -3.575 | nHRing | 0 |
| Solubility: LogP | 3.153 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.6463 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.655 |
| Synth | 2.147 |
| Natural Product Likeliness | 0.785 |
| NR-PPAR-gamma | 0.828 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.023 |
| HIA | 0.009 |
| CACO-2 | -4.83 |
| MDCK | 0.000014 |
| BBB | 0.104 |
| PPB | 0.997316 |
| VDSS | 0.513 |
| FU | 0.0115816 |
| CYP1A2-inh | 0.967 |
| CYP1A2-sub | 0.909 |
| CYP2c19-inh | 0.797 |
| CYP2c19-sub | 0.118 |
| CYP2c9-inh | 0.664 |
| CYP2c9-sub | 0.951 |
| CYP2d6-inh | 0.617 |
| CYP2d6-sub | 0.914 |
| CYP3a4-inh | 0.879 |
| CYP3a4-sub | 0.264 |
| CL | 12.496 |
| T12 | 0.856 |
| hERG | 0.098 |
| Ames | 0.749 |
| ROA | 0.711 |
| SkinSen | 0.934 |
| Carcinogencity | 0.642 |
| EI | 0.967 |
| Respiratory | 0.799 |
| NR-Aromatase | 0.789 |
| Antiviral | No |
| Prediction | 0.609036 |